Acadia Healthcare Company, Inc. (NASDAQ:ACHC) – Jefferies Group reduced their FY2017 earnings per share estimates for Acadia Healthcare in a research note issued on Tuesday. Jefferies Group analyst B. Tanquilut now expects that the company will post earnings per share of $2.45 for the year, down from their prior forecast of $2.47. Jefferies Group has a “Buy” rating and a $60.00 price target on the stock. Jefferies Group also issued estimates for Acadia Healthcare’s Q4 2017 earnings at $0.68 EPS.
Several other research analysts have also issued reports on ACHC. Zacks Investment Research lowered shares of Acadia Healthcare from a “hold” rating to a “sell” rating in a research report on Thursday. Craig Hallum restated a “buy” rating and issued a $65.00 price target (up previously from $52.00) on shares of Acadia Healthcare in a research report on Monday, July 31st. UBS AG restated a “positive” rating and issued a $60.00 price target (up previously from $54.00) on shares of Acadia Healthcare in a research report on Monday, July 31st. BidaskClub lowered shares of Acadia Healthcare from a “hold” rating to a “sell” rating in a research report on Friday, August 18th. Finally, Deutsche Bank AG lifted their price target on shares of Acadia Healthcare from $58.00 to $60.00 and gave the stock a “buy” rating in a research report on Monday, July 31st. Two research analysts have rated the stock with a sell rating, two have given a hold rating, nine have given a buy rating and one has assigned a strong buy rating to the company. The stock has a consensus rating of “Buy” and an average target price of $57.40.
COPYRIGHT VIOLATION NOTICE: “FY2017 Earnings Forecast for Acadia Healthcare Company, Inc. (ACHC) Issued By Jefferies Group” was first posted by Ticker Report and is the property of of Ticker Report. If you are accessing this piece of content on another site, it was stolen and republished in violation of international copyright and trademark law. The legal version of this piece of content can be accessed at https://www.tickerreport.com/banking-finance/2957144/fy2017-earnings-forecast-for-acadia-healthcare-company-inc-achc-issued-by-jefferies-group.html.
Shares of Acadia Healthcare (ACHC) opened at 43.30 on Thursday. The stock’s 50 day moving average price is $46.21 and its 200 day moving average price is $46.34. The stock has a market cap of $3.80 billion, a price-to-earnings ratio of 475.82 and a beta of 1.07. Acadia Healthcare has a 52 week low of $32.54 and a 52 week high of $54.34.
Acadia Healthcare (NASDAQ:ACHC) last announced its quarterly earnings results on Thursday, July 27th. The company reported $0.66 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.65 by $0.01. The business had revenue of $715.90 million for the quarter, compared to analyst estimates of $717.38 million. Acadia Healthcare had a return on equity of 8.69% and a net margin of 0.30%. The company’s quarterly revenue was down 5.4% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.73 EPS.
In related news, insider Scott Schwieger sold 2,891 shares of the firm’s stock in a transaction that occurred on Monday, July 31st. The shares were sold at an average price of $52.85, for a total value of $152,789.35. Following the completion of the transaction, the insider now owns 8,841 shares of the company’s stock, valued at approximately $467,246.85. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, President Brent Turner sold 206,252 shares of the firm’s stock in a transaction that occurred on Tuesday, August 22nd. The stock was sold at an average price of $50.69, for a total transaction of $10,454,913.88. Following the completion of the transaction, the president now directly owns 81,106 shares of the company’s stock, valued at approximately $4,111,263.14. The disclosure for this sale can be found here. Insiders sold a total of 3,085,693 shares of company stock valued at $157,729,099 in the last ninety days. Company insiders own 11.10% of the company’s stock.
A number of institutional investors have recently bought and sold shares of the stock. Davidson Kempner Capital Management LP boosted its stake in Acadia Healthcare by 16.7% in the 2nd quarter. Davidson Kempner Capital Management LP now owns 350,000 shares of the company’s stock worth $17,283,000 after purchasing an additional 50,000 shares during the period. Public Employees Retirement System of Ohio boosted its stake in Acadia Healthcare by 10.9% in the 2nd quarter. Public Employees Retirement System of Ohio now owns 81,729 shares of the company’s stock worth $4,036,000 after purchasing an additional 8,066 shares during the period. Asymmetry Capital Management L.P. boosted its stake in Acadia Healthcare by 594.0% in the 2nd quarter. Asymmetry Capital Management L.P. now owns 82,694 shares of the company’s stock worth $4,083,000 after purchasing an additional 70,779 shares during the period. Ameritas Investment Partners Inc. acquired a new position in Acadia Healthcare in the 2nd quarter worth approximately $1,129,000. Finally, Raymond James Financial Services Advisors Inc. boosted its stake in Acadia Healthcare by 346.0% in the 2nd quarter. Raymond James Financial Services Advisors Inc. now owns 34,757 shares of the company’s stock worth $1,716,000 after purchasing an additional 26,964 shares during the period.
Acadia Healthcare Company Profile
Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.
Receive News & Ratings for Acadia Healthcare Company Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare Company Inc. and related companies with MarketBeat.com's FREE daily email newsletter.